The Characteristics of Amiodarone-induced Thyrotoxicosis in a Moderate Iodine Deficit Area

1. Fuks AG, Vaisman M, Buescu. Thyroid dysfunction and cardiological management in patients receiving amiodarone. Arquivos Brasileiros de Cardiologia. 2004;82(6):528-532.Search in Google Scholar

2. Siddoway LA. Amiodarone: guidelines for use and monitoring. American family physician. 2003;68(11):2189-96.Search in Google Scholar

3. Podrid PJ. Amiodarone reevaluation of an old drug. Ann. Intern. Med. 1995;122:689-700.10.7326/0003-4819-122-9-199505010-00008Search in Google Scholar

4. Beddows S, Page S, Taylor A, et al. Cytotoxic effects of amiodarone and desethylamiodarone on human thyrocytes. Biochem. Pharmacol. 1989;38:4397-4403.Search in Google Scholar

5. Basaria S, Cooper D. Amiodarone and the thyroid. Am. J. Med. 2005;118:706-714.10.1016/j.amjmed.2004.11.028Search in Google Scholar

6. Padmanabhan H. Amiodarone and thyroid disfunction. South Med. J. A. 2010;103(9):922-930.Search in Google Scholar

7. Trip M, Wiersinga W, Plomp T. Incidence, predictability and pathogenesis of amiodarone - induced thyrotoxicosis and hypothyroidism. Am. J. Med. 1991;91:507-511.10.1016/0002-9343(91)90187-3Search in Google Scholar

8. Hofman A, Nawara C, Ofl uoglu S, et al. Incidence and predictability of amiodaroneinduced thyrotoxicosis and hypothyroidism. Wien Klin Wochenschr. 2008;120(15-16):493-8.10.1007/s00508-008-1017-218820854Search in Google Scholar

9. Martino E, Aghini-Lombardi F, Mariotti S, et al. Amiodarone: a common source of iodine-induced thyrotoxicosis. Horm Res. 1987;26:158.10.1159/0001806962885251Search in Google Scholar

10. Martino E, Bartalena L, Bogazzi F, et al. The effects of amiodarone on the thyroid. Endocr. Rev. 2001;22:240-254.Search in Google Scholar

11. Bogazzi F, Martino E, Dell Unto E et al. Thyroid color fl ow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced tyrotoxicosis. J Endocrinol Invest. 2003;26(7):635-640.10.1007/BF0334702114594114Search in Google Scholar

12. Bogazzi F, Bartalena L, Tomisi L et al. Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive tyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. J Clin Endocrinol Metab. 2007;92:556-562.10.1210/jc.2006-205917148557Search in Google Scholar

13. Piga M, Serra A, Boi F et al. Amiodarone- induced thyrotoxicosis. A review. Minerva Endocrinol. 2008;33(3):213-228.Search in Google Scholar

14. Goldschlager N, Epstein AE, Naccarelli GV, et al. A practical guide for clinicians who treat patients with amiodarone. Heart Rhythm. 2007;4(9):1250-1259.10.1016/j.hrthm.2007.07.02017765636Search in Google Scholar

15. Franklyn JA. Amiodarone and thyroid hormone action. Clin. Endocinol. 1985;22:257.Search in Google Scholar

16. Gopalan M. Thyroid dysfunction induced by amiodarone therapy. Updated: Jul 2, 2009. Workup http://emedicine.medscape.com/article/129033-workup#a0723.Search in Google Scholar

17. Sidhu J, Jenkins D. Men are at increased risk of amiodarone-induced thyrotoxicosis in the UK. QJM. 2003;12:949-950.10.1093/qjmed/hcg15814631062Search in Google Scholar

18. Aleksic Z, Aleksic A. Incidence of amiodarone-induced thyroid disfunction and predictive factors for theier occurrence. Med Pregl. 2011;64(11-12): 533-538.10.2298/MPNS1112533ASearch in Google Scholar

19. Liang YL, Huang SM, Peng SL, et al. Amiodarone-induced thyrotoxicosis in a patient with autonomously functioning nodular goiter. Ann Pharmacother. 2009;43(1):134-8.10.1345/aph.1L34719109209Search in Google Scholar

20. Tomisti L, Dell’Unto E, Brogioni S, et al. Amiodarone induced thyrotoxicosis in patients with multinodular goiter: type 1 or type 2 AIT? Endocr Abst. 2010;22:765.Search in Google Scholar

21. Davis AB, Orlander PR. Goiter, Toxic Nodular. Updated: Apr 26, 2010. Available from: http://emedicine.medscape.com/article/120497-overview.Search in Google Scholar

22. Bogazzi F, Bartalena L, Dell’Unto E, et al. Proportion of type 1 and type 2 Amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy. Clin Endocrinol. 2007;67:533-537.10.1111/j.1365-2265.2007.02920.x17561980Search in Google Scholar

23. Zosin I, Balas M. Amiodarone induced thyroid disfunction in an iodine replete area: epidemiological and clinical data. Polish Jurnal Endoc. 2012;63(1):2-9.Search in Google Scholar

24. Binz K, Burger A, Vallotton MB. Amiodarone and thyroid function: clinical implications. Schweiz Med Wochenschr. 1998;128:1051-1058.Search in Google Scholar

25. Fiorini A. Monitoring thyroid function status in elderly patients on amiodarone. Malta Med J. 2006;18-24.Search in Google Scholar

26. Kun I, Szántó Z, Balázs J, et al. Detection of Iodine Defi ciency Disorders (Goiter and Hypothyroidism) in School-Children Living in Endemic Mountainous Regions, After the Implementation of Universal Salt Iodization. Hot Topics in Endocrine and Endocrine-Related Diseases, Dr. Monica Fedele (Ed.), ISBN: 978-953-51-1080-4, InTech, DOI: 10.5772/54188.10.5772/54188Search in Google Scholar

27. Simescu M, Dumitriu L, Kun I, et al. Urinary Iodine Levels in Schoolchildren and Pregnant Women After the Legislative Changes in the Salt Iodization. Acta Endocrinologica New series. 2006;2(1):33-44.10.4183/aeb.2006.33Search in Google Scholar

28. Toma A, Sava M, Delia C, et al. Universal Salt Iodization Effects on Endemic Goiter in Arges County, Romania. Acta Endocrinologica (Bucharest), New series. 2005;1(2):167-180.10.4183/aeb.2005.167Search in Google Scholar